7 things to know
about
TRT & HRT.

A useful first appointment connects symptoms with medical history, medicines, sleep, mental health and examination findings. The goal is an appropriate diagnosis and a measurable improvement—not simply a higher laboratory number. [36]

TRT can help the right patient. Its benefits have limits.

In men with documented low testosterone, trials found improvements in sexual function, anemia and bone density. Improvements in energy, walking ability and mood were smaller or inconsistent; memory did not improve. These results do not establish testosterone as a general anti-aging, bodybuilding or weight-loss treatment. [4]

Choose a concrete goal with the prescriber: improved sexual symptoms, correction of anemia or another documented problem. Reassess whether treatment is delivering that benefit rather than continuing automatically because a blood result improved. [3]

Discuss fertility, blood counts and heart health before TRT.

Testosterone can suppress sperm production and reduce fertility. It may also cause acne, fluid retention, breast symptoms and a high red-blood-cell concentration (hematocrit). Tell the clinician about fertility plans before starting. Testosterone is not a reliable contraceptive. [2] [8]

Conditions that can make starting TRT inappropriate include prostate or breast cancer, elevated hematocrit, untreated severe sleep apnea, severe urinary symptoms, uncontrolled heart failure, a recent heart attack or stroke, and thrombophilia. Prostate concerns require evaluation; recommendations differ for carefully selected patients after cancer treatment. [1] [3]

TRAVERSE studied 5,246 men aged 45–80 with low testosterone and existing or elevated cardiovascular risk. Major cardiovascular events occurred in 7.0% with testosterone gel and 7.3% with placebo over about 33 months of follow-up. Atrial fibrillation, acute kidney injury and pulmonary embolism were more frequent with testosterone. The findings do not prove lifelong safety or apply to high-dose anabolic use. [5]

Menopausal HRT is usually about symptom relief.

Systemic hormone therapy is the most effective treatment for bothersome hot flashes and night sweats and can prevent bone loss. For many healthy symptomatic people younger than 60 or within 10 years of menopause, benefits can outweigh risks. Starting later generally has a less favorable risk balance; decisions remain individual. It is not prescribed simply to prevent heart disease or dementia. [12]

When symptoms are limited to vaginal dryness, pain with sex or certain urinary symptoms, a local vaginal treatment may be enough. Low-dose vaginal estrogen has much lower systemic exposure and is not a treatment for hot flashes. The specific vaginal ring matters: some rings deliver systemic estrogen. [15]

Early menopause (before 45) or primary ovarian insufficiency (before 40) deserves a separate discussion about bone and long-term health. Unless contraindicated, hormone therapy is often recommended until around the usual menopause age. Ovulation can still occur with ovarian insufficiency; contraception may still be needed. [24]

HRT risks depend on the person and the regimen.

Possible adverse effects include breast tenderness, nausea and spotting. Systemic treatment can increase clot and stroke risk; breast-cancer risk differs between estrogen alone and estrogen plus a progestogen, and with duration. Unexplained bleeding, hormone-sensitive cancer, previous clots or cardiovascular disease, and liver disease require careful review. Vaginal symptoms after breast cancer may still have treatment options through shared decision-making with the cancer team. [11] [12]

FDA requested revised menopausal-hormone labels in November 2025. Its February 2026 announcement approved changes for six products, removing cardiovascular, breast-cancer and probable-dementia statements from their boxed warnings. This did not mean all safety concerns disappeared or every product label had already changed. [18] [19]

The testosterone formulation changes the daily experience.

These are educational examples of prescription treatments, not a confirmed OptimalMD formulary. Brand, strength, route, availability and price must be checked for the actual prescription. Do not change products or doses on your own.

Fertility-preserving approaches are a separate discussion. A specialist may consider hCG or medicines such as clomiphene in selected men; some uses are off-label. These are not routine additions to every TRT prescription. Anastrozole should not be treated as an automatic requirement. [3]

Estrogen, progesterone and local therapy do different jobs.

Another systemic option for certain postmenopausal patients with a uterus is conjugated estrogens plus bazedoxifene (Duavee). Bazedoxifene helps protect the uterine lining instead of adding a progestogen. This is a specific combination with its own clot and other warnings—not a reason to omit protection from a different estrogen prescription. [39]

For vaginal symptoms, prasterone (Intrarosa) is a vaginal DHEA insert for painful intercourse; it is a prescription hormone treatment, not an interchangeable substitute for an over-the-counter supplement. Ospemifene (Osphena) is an oral estrogen-receptor modulator for painful intercourse or vaginal dryness; it has endometrial and clot warnings. Both need individual review, especially after breast cancer. [37] [38]

Medication names on this page explain the choices; they are not a promise that a particular brand is supplied or included at $0 through OptimalMD. The clinician chooses the medicine, formulation and schedule with you.

“Bioidentical” does not mean safer, and testosterone for women is a separate decision.

Some FDA-approved estradiol and progesterone medicines are chemically identical to human hormones. “Bioidentical” does not automatically mean custom-compounded. Compounded preparations are not FDA-approved, and claims that they are safer or more effective are not established. Saliva-based dosing and hormone “balancing” panels are not a reliable shortcut to an individualized regimen. [21]

ACOG recommends approved menopausal hormone products over compounded products when suitable approved options exist. For testosterone delivery in women, it recommends alternatives to pellets because safety data are limited and pellets cannot readily be removed. A specific compounding need should be explained by the prescriber. [20]

Testosterone may be considered off-label for selected postmenopausal women with distressing hypoactive sexual desire disorder after a full assessment. It is not an established treatment for general fatigue, weight loss or “brain fog.” There is no FDA-approved testosterone product specifically for women; monitoring should avoid excessive levels and androgen effects such as acne, unwanted hair and voice changes. OptimalMD availability for this specific indication is not confirmed. [22]

During TRT, reassess symptoms, adverse effects, testosterone, hematocrit and blood pressure; prostate monitoring depends on age and risk. Testing is timed to the formulation and repeated after changes, then periodically. Menopausal HRT is commonly reviewed around three months and at least annually thereafter, sooner for problems. Persistent or new bleeding needs evaluation. [1] [23]

Bring every prescription, supplement and nonprescription medicine to the review. Hormones may interact with other treatments, and laboratory timing matters. Do not stop or adjust a prescribed hormone without a plan from the treating clinician. [10] [16]

The family membership can support much more than the hormone prescription.

OptimalMD currently advertises its Family Plan at $149 per month for up to seven household members, and an Individual Plan at $99. It is a healthcare membership, not health insurance. Each person still needs an individual clinical assessment. The household membership does not entitle everyone to hormone prescriptions. [28]

The broader Prime package also lists talk therapy, three dermatology visits, care coordination, virtual veterinary help and pet-prescription discounts, Fullscript discounts and an AI diagnosis companion. Psychology, psychiatry, in-person care and optional programs have their own terms and may carry additional fees. An AI companion does not diagnose or prescribe in place of a clinician. [29]

Confirm the hormone pathway and the full cost before enrolling for treatment.

OptimalMD’s public medication page explicitly lists hormone replacement therapy as available specialty care. Its public materials also describe hormone labs and specialist access. They do not establish a universal $0 TRT/HRT package or a confirmed list of hormone drugs, strengths and prices for every member. [31] [32]

Federal telemedicine flexibilities currently run through December 31, 2026, subject to federal and state requirements. They permit certain prescribing; they do not require a provider to prescribe testosterone or establish OptimalMD’s own service availability. An in-person visit may still be necessary. [35]

Paying for membership does not guarantee eligibility for a treatment. Confirm the service and written quote before paying specifically to obtain hormones. The regular membership does not replace hospital or emergency insurance; Impact Health Sharing is a separate offering with separate rules. [34]

Hormones are not the only option

For menopause symptoms, options can include cognitive behavioral therapy, certain SSRIs/SNRIs, gabapentin and other clinician-selected nonhormonal treatments. Moisturizers and lubricants can help vaginal dryness. Sleep, exercise, nutrition and mental-health care support wellbeing, whether or not hormones are used. Treating sleep apnea, obesity or medication-related causes can also matter in a low-testosterone evaluation. [25] [36]

Fezolinetant (Veozah) is a nonhormonal hot-flash treatment with a boxed warning for rare serious liver injury and required liver testing. Elinzanetant (Lynkuet), approved in October 2025, is another nonhormonal option with its own precautions. Neither should be assumed to be included in OptimalMD’s $0 medication list. [26] [27]

Bring these questions

• What diagnosis explains my symptoms, and what else should be ruled out?
• What improvement is realistic, how long will we try treatment, and when would we stop?
• How do my fertility plans, uterus status, cancer history, blood pressure or clot risk affect the choice?
• Which exact medicine and route do you recommend, and why? Is any use off-label or compounded?
• Who orders and reviews my labs, handles side effects and provides refills?
• What is my total ongoing cost, including anything outside the family membership?

Already a member? Use your member portal or call OptimalMD at (855) 378-7700 to confirm the hormone-care pathway. OmniGLP can help with membership information; the licensed treating clinician makes medical decisions.